Xi'an ruixi Biological Technology Co

Home > Keywords >

Catalog	name	Description	price
R-C-3085	EG00229 CAS:1018927-63-3	EG00229 is a Neuropilin 1(NRP1)receptor antagonist. EG00229 inhibits VEGFA binding to NRP1.Only for scientific research, not for human body.	price>
R-R-4755	5-PA-dUTP CAS No.179101-49-6	5-PA-dUTP (5-Propargylamino-dUTP)/CAS No.179101-49-6 is a C5-modified nucleotide and can be incorporated into DNA nanoparticles (DNPs) for photosensitizer delivery. 5-PA-dUTP is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.	price>
R-C-3086	R1530 CAS:882531-87-5	R1530 is a pyrazolobenzodiazepine small molecule with potential antiangiogenesis and antineoplastic activities.Only for scientific research, not for human body.	price>
R-R-4756	NSC 80467 CAS No.101982-51-8	NSC 80467/CAS No.101982-51-8, a DNA damaging agent, selectively inhibits survivin. NSC 80467 preferentially inhibits DNA synthesis and results in induction of γH2AX and pKAP1, two markers of DNA damage.	price>
R-C-3087	SUN11602 CAS:704869-38-5	SUN11602 is a small synthetic compound that mimics the neuroprotective activities of bFGF and activates key molecules in the FGF receptor-1-mitogen-activated protein kinase/extracellular signal-regulated kinase-1/2 kinase (FGFR-1-MEK/ERK) signaling pathway.Only for scientific research, not for human body.	price>
R-R-4757	MC-VC-PAB-Cyclohexanediamine-Thailanstatin A CAS No.1609108-96-4	MC-VC-PAB-Cyclohexanediamine-Thailanstatin A/CAS No.1609108-96-4 is a Spliceostatin (HY-16466) analog, and a drug-linker conjugates for ADC, consisting of ADC Cytotoxin Thailanstatin A (HY-129589) and cleavable ADC linker (MC-vc-PAB). MC-VC-PAB-Cyclohexanediamine-Thailanstatin A can be used for ADC synthesis.	price>
R-C-3088	SU4312 CAS: 5812-07-7	SU-4312, also known as DMBI, is a potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC50 values are 0.8 and 19.4 μM respectively).Only for scientific research, not for human body.	price>
R-R-4758	FAICAR CAS No.13018-54-7	FAICAR (5-Formamidoimidazole-4-carboxamide ribotide)/CAS No.13018-54-7 is a purine nucleotide.	price>
R-C-3089	CEP-11981 cas: 856691-93-5	CEP-11981(ESK981)is an orally bioavailable inhibitor of vascular endothelial growth factor receptor (VEGFR) and Tie2 receptor tyrosine kinases with potential antiangiogenic and antineoplastic activities. Only for scientific research, not for human body.	price>
R-R-4759	Cytarabine-d2 CAS No.40632-26-6	Cytarabine-d2/CAS No.40632-26-6 is the deuterium labeled Cytarabine. Cytarabine, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine has antiviral effects against HSV.	price>
R-C-3090	Tyrphostin 9 CAS:10537-47-0	Tyrphostin 9 (SF 6847, RG-50872) is firstly designed as an EGFR inhibitor with IC50 of 460 μM, but is also found to be more potent to PDGFR with IC50 of 0.5 μM.Only for scientific research, not for human body.	price>
R-R-4760	ddTTP trisodium	ddTTP trisodium is one of 2,3-dideoxyribonucleoside 5-triphosphates (ddNTPs) that acts as chain-elongating inhibitor of DNA polymerase for DNA sequencing.	price>
R-C-3091	TAK-593 CAS:1005780-62-0	TAK-593 is an oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity.Only for scientific research, not for human body.	price>
R-R-4761	WRN inhibitor 1 CAS No.2923008-44-8	WRN inhibitor 1 (example 7)/CAS No.2923008-44-8 is a Wemer Syndrome ATP dependent helicase enzyme (WRN) inhibitor that inhibits WRN helicase domain activity. WRN inhibitor 1 has the potential to study cancer.	price>
R-C-3092	SU5402 CAS:215543-92-3	SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.Only for scientific research, not for human body.	price>
R-R-4762	Remdesivir-d5	Remdesivir-d5 is a deuterium labeled Remdesivir. Remdesivir (GS-5734) is a nucleoside analogue, with effective antiviral activity, with EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Remdesivir is highly effective in the control of 2019-nCoV (COVID-19) infection in vitro.	price>
R-C-3093	SAR131675 CAS:1433953-83-3	SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.Only for scientific research, not for human body.	price>
R-R-4763	H3B-8800 CAS No.1825302-42-8	H3B-8800/CAS No.1825302-42-8 is a potent and orally active SF3B splicing modulator. H3B-8800 direct interaction with the SF3b complex and shows anti-cancer activity. H3B-8800 has the potential for the research of acute myeloid leukemia (AML) with SF3B1 mutant.	price>
R-C-3094	SU 5416 (Semaxinib) CAS: 204005-46-9	SU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and RET.Only for scientific research, not for human body.	price>
R-R-4764	Setrobuvir CAS No.1071517-39-9	Setrobuvir (ANA598)/CAS No.1071517-39-9 is an orally active non-nucleosidic HCV NS5B polymerase inhibitor. ANA-598 inhibits both de novo RNA synthesis and primer extension, with IC50s between 4 and 5 nM. Setrobuvir also shows excellent binding affinity to SARS-CoV-2 RdRp and induces RdRp inhibition.	price>

680681682683684685 686687688689690